OTC (over-the-counter) diagnostics and mix/match hip implants under MHRA (Medicines & Healthcare Products Regulatory Agency) scrutiny
This article was originally published in Clinica
Executive Summary
The UK's over-the-counter diagnostics market and the "general practice of mixing and matching hip replacement implants" contrary to manufacturers instructions are among the areas under closest scrutiny by the Medicines and Healthcare products Regulatory Agency (MHRA).